The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.
about
Effects of statins in patients with chronic kidney disease: meta-analysis and meta-regression of randomised controlled trialsLipid and inflammatory biomarkers and kidney function decline in type 2 diabetes.Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.4D MRI of polycystic kidneys from rapamycin-treated Glis3-deficient miceLongitudinal Association Between Endothelial Dysfunction, Inflammation, and Clotting Biomarkers With Subclinical Atherosclerosis in Type 1 Diabetes: An Evaluation of the DCCT/EDIC CohortCirculating TNF receptors 1 and 2 predict ESRD in type 2 diabetesTumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes.Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes.Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.Systemic and renal lipids in kidney disease development and progression.Novel biomarkers for the progression of diabetic nephropathy: soluble TNF receptors.Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge.Renal vascular inflammation induced by Western diet in ApoE-null mice quantified by (19)F NMR of VCAM-1 targeted nanobeacons.Elevated Serum Lysophosphatidylcholine in Patients with Systemic Lupus Erythematosus Impairs Phagocytosis of Necrotic Cells In Vitro.Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes.Cilostazol effectively attenuates deterioration of albuminuria in patients with type 2 diabetes: a randomized, placebo-controlled trial.Association of TNF Receptor 2 and CRP with GFR Decline in the General Nondiabetic Population.Obesity-associated glomerular inflammation increases albuminuria without renal histological changes.Association of C-Reactive Protein and Other Markers of Inflammation with Risk of Complications in Diabetic Subjects.The effect of admission creatinine levels on one-year mortality in acute myocardial infarction
P2860
Q30841365-D7A08430-D533-447E-AA51-5485AFC14369Q33604107-174E2054-10FD-4006-A58F-37F3142FA99BQ33776181-C897B451-FA6B-42BD-9F25-3086D38827BCQ33892230-009DF1FB-E7E6-4CFE-ACC6-BF174E47F73FQ35025400-2E47B3CA-CA5D-4C35-8FC1-EFEEA54AE5FEQ35450353-FBDD99C1-51D4-4412-8BCA-2DA8A8665464Q35769521-93EC2B1E-7A15-4F0B-B539-08828C6D52FBQ35804201-01DA3FC1-E22B-4CFC-A536-51CE401EFAB8Q36723318-F20D101F-B260-4620-B2AD-B265F941D131Q37042111-764A1F79-4541-46B8-8B73-C5C7B65D883AQ37121789-C7DFF8CD-163D-4FB7-AD73-849B66AD5A7BQ37148885-24AA1C87-26DB-4BE1-8717-BB9225D74E2BQ38105277-5D74CEAC-9C4A-4D2F-9FEE-734742FDE65BQ38255902-116F050C-3071-4258-BFEE-8DC352518B1BQ38372669-9E175DEC-5446-4438-AEAF-4DF72C97E93DQ41868060-6FAE21B0-F836-4E06-908C-6B3CBF38ECA6Q49539707-751B84C6-19CA-4244-9EED-EA5771BA9878Q50789643-B57594BE-1245-4540-B732-0FC36C186181Q50900167-BDE33117-8250-4F3B-AEA4-EC451F2BBD8BQ51155704-F5613215-8D37-4EA3-B89D-8A35692146D4Q53831433-A01BA4DC-7CC5-457E-B3AE-D9112CF5BF32Q55221890-4BB39CD9-050B-435B-BA53-542EEC319B93Q58914650-F7C5F2DD-4682-44BA-A659-B6835E87C259
P2860
The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The association of serum lipid ...... ith type II diabetes mellitus.
@ast
The association of serum lipid ...... ith type II diabetes mellitus.
@en
type
label
The association of serum lipid ...... ith type II diabetes mellitus.
@ast
The association of serum lipid ...... ith type II diabetes mellitus.
@en
prefLabel
The association of serum lipid ...... ith type II diabetes mellitus.
@ast
The association of serum lipid ...... ith type II diabetes mellitus.
@en
P2093
P2860
P356
P1433
P1476
The association of serum lipid ...... ith type II diabetes mellitus.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.KI.5000021
P407
P577
2006-01-01T00:00:00Z